Matches in Nanopublications for { ?s ?p "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP70507.RAfdGU4mPc3FTwP4rSRf40OAYALhHN9kD74zHG8NhN6Tc130_assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70507.RAfdGU4mPc3FTwP4rSRf40OAYALhHN9kD74zHG8NhN6Tc130_provenance.
- assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP72042.RAYc6Z7OWA-d0yhHAxbXzCms0Ee53zI2d-Irxlc7UnYro130_assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP72042.RAYc6Z7OWA-d0yhHAxbXzCms0Ee53zI2d-Irxlc7UnYro130_provenance.
- NP70492.RAlGVHT2pbjgns-_fvsKhFZHgBnCLY8R6f0YEuSvOOhO4130_assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70492.RAlGVHT2pbjgns-_fvsKhFZHgBnCLY8R6f0YEuSvOOhO4130_provenance.
- NP70500.RA3RYnl9wT__GryIQljXjF2UcLKAfO2u8rowf1fCcdSiQ130_assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70500.RA3RYnl9wT__GryIQljXjF2UcLKAfO2u8rowf1fCcdSiQ130_provenance.
- NP72041.RAhfHGktFI3zWo9q75QuhSVvBsDoQcsEUGUbgt8KSDJbQ130_assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP72041.RAhfHGktFI3zWo9q75QuhSVvBsDoQcsEUGUbgt8KSDJbQ130_provenance.
- NP72040.RA8Yv_cxOzvEP9vS9ethm-VK2jxy4mSM08kVXaTxYFIX4130_assertion description "[In contrast, there was no evidence that Pl(A2) influenced the rate of recurrent events in placebo-treated patients. In patients presenting with an acute coronary syndrome, the Pl(A) polymorphism of GPIIb/IIIa may explain some of the variance in the respon]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP72040.RA8Yv_cxOzvEP9vS9ethm-VK2jxy4mSM08kVXaTxYFIX4130_provenance.